Superworth

Neuronetics price to book ratio STIM

Market value divided by the book value of the company's net assets, since 2018.

Today, Nov 2, 2026
8.8×
8-year median
2.8×
Against its 8-year history
89th
percentile: 0 is its lowest day, 100 its highest
8-year range
0.6× to 16.4×
Peer median
2.3×

Neuronetics' price to book ratio is 8.8× as of Nov 2, 2026.

That is above its 8-year median of 2.8×, higher than on 89% of days in the last 8 years.

Over that time it ranged from 0.6× in Apr 2020 to 16.4× in Mar 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 2.3×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far8.8×3.2×14.1×
20253.6×3.3×16.4×
20244.8×1.1×4.8×
20232.2×0.7×2.9×
20223.0×0.8×3.0×
20211.3×1.1×14.7×
20207.7×0.6×7.7×
20191.5×1.4×4.4×
20184.4×4.1×5.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Neuronetics' size, closest first, today.

CompanyPrice to book ratio
STIMNeuronetics8.8×
PDEXPro DEX3.7×
UTMDUtah Medical Products1.8×
KEQUKewaunee Scientific1.3×
INFUInfuSystem4.7×
EMBCEmbectan/m
APTAlpha Pro Tech0.9×
TCMDTactile Systems Technology2.3×
NEPHNephros2.9×
MOVMovado1.4×
IRMDIradimed9.5×
Peer median2.3×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Neuronetics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.